EXPERTISE PARTNERS
Asymchem
Your Trusted CDMO Pharmaceutical Partner. Our solutions range from early clinical stage to commercial stage, including R&D and cGMP production of advanced intermediates, APIs, formulations, as well as clinical research services. Through strategic partnerships and calculated business growth, we have built an integrated service ecosystem
Hongene Biotech
Established in 1998, Hongene Biotech has been specialized in the production of nucleic acid raw materials for more than 25 years, covering nucleosides and modified nucleosides, nucleotides, phosphoramidite, GalNAc delivery molecules and enzymes. The annual capacity of phosphoramidite is 58 tons and nucleoside triphosphates is 54,000 litres (equivalent of 1.05 billion doses of mRNA vaccines). To date, Hongene has over 1,600 employees globally with over 400 R&D staff. Hongene brand is highly recognized by major pharmaceutical companies and biotech companies developing mRNA and oligonucleotide drugs. Hongene's products have entered almost all nucleic acid drug pipelines worldwide. During the Covid 19 pandemic, Hongene was the largest supplier of raw materials used in billions of mRNA COVID-19 vaccines. Currently, the company has established end-to-end mRNA CDMO capability, provide one-stop shopping from raw materials to final product, supporting clients from preclinical research to commercialization.
WuXi TIDES
WuXi TIDES, part of Wuxi AppTec, is a unique Contract Research, Development and Manufacturing
platform. WuXi TIDES offers our partners efficient, flexible, and high-quality solutions from discovery
through the commercial supply of oligonucleotides, peptides and related synthetic conjugates
(“TIDES” drugs).
EXHIBITION PARTNERS
ChemGenes
Established in 1981, ChemGenes is the industry leader in manufacturing oligonucleotide synthesis
reagents and has consistently provided the highest quality phosphoramidites and solid supports
in the market. Our facility, just outside of Boston/Cambridge Massachusetts USA, is setup for bulk
manufacturing of therapeutic grade phosphoramidite and solid support DNA/RNA synthesis products
for GMP grade oligonucleotide manufacturing. ChemGenes carries the widest variety of modified
phosphoramidites and supports currently used in oligonucleotide synthesis including Microarray
Technology, Oligonucleotide Therapeutics, Oligonucleotide Based Probes and other areas of Nucleic
Acid research. In addition, ChemGenes is expanding its custom oligonucleotide synthesis department specializing in the manufacture of ASOs, siRNA, gRNA, gapmers, aptamers, DNA based probes, and superior quality beads for Single Cell mRNA sequencing applications using Drop-Seq, Slide-seq, and Seq-Well methods. ChemGenes remains devoted to providing you with invaluable customer service and comprehensive technical support
Synoligo Biotechnologies Inc.
Headquartered in Morrisville, NC, USA, Synoligo Biotechnologies is a Contract Research and Development Organization (CRDO) specialized in manufacturing complex and highly modified oligonucleotide for academic, biotech start-up and large pharmaceutical communities. Synoligo is a leading oligonucleotide manufacturing company providing high quality, cost-effective custom oligonucleotides at varying scales for research, diagnostic, and therapeutic applications.